focus -WSS

focus

author：fashion 2025-09-28 23:05:36 - browse：82494

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： H5N1 bird flu: what we're starting to learn about infection in cows

WSS

The Readout: Lenmeldy, GLP

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Elevance, private equity launch primary care company

Shionogi licenses Pompe disease therapy from Maze Therapeutics

The Readout: Lenmeldy, GLP

First recipient of genetically engineered pig kidney has died

focus

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

In Memoriam: Notable people who died in 2023

Primary care physicians play key roles in Alzheimer's management

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Telehealth startups turn to complex chronic diseases

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Study: Adult vaccinations pay for themselves in societal benefits

hotspot

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

First recipient of genetically engineered pig kidney has died

Scientists boost immune system in aging mice by making it youthful

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Sanofi strikes deal with Novavax, boosting the vaccine maker

Why the world’s most expensive drug might be worth the price

hotspot

focus

leisure time

focus